[March 11 After-Market Update | Quick Overview of Premium Risk Announcements for Shanghai and Shenzhen Funds in the Secondary Market] 1. After the market closed on March 11, seven funds, including the Soybean Meal ETF, S&P 500 ETF, Nikkei ETF, S&P O

The EIA's implied demand for U.S. distillate fuel oil production for the week ending March 6 was 5.3157 million barrels per day, compared to 4.9247 million barrels per day in the previous week.

Individual Stock News 1. Jihai Gold (02489.HK): Yantai Zhongjia's open-pit mine has resumed production. 2. Paige Biopharmaceutical-B (02565.HK): The trading unit for the main board will be changed from 500 H shares to 50 H shares, effective from 9:00 a.m. on March 31, 2026. 3. Chongqing Machinery & Electric (02722.HK) issued a profit warning: It expects annual profit attributable to shareholders to increase by 70%-75% year-on-year. 4. Wuling Motors (00305.HK) issued a profit warning: It expects profit attributable to shareholders for 2025 to increase by approximately 54% year-on-year. 5. Yue Yuen Group (00551.HK): Net operating income in February was US$675 million, an increase of 19.4% year-on-year. 6. Pou Sheng International (03813.HK): Net operating income for February was approximately RMB 1.9515 billion, up 81.5% year-on-year. 7. Wugu Mofang (01837.HK) issued a profit warning: Annual net profit is expected to be approximately RMB 260 million to RMB 265 million, up 38% to 41% year-on-year. 8. China Resources Beer (00291.HK) issued a profit warning: Annual profit is expected to be RMB 2.92 billion to RMB 3.35 billion, down approximately 29.6% to 38.6% year-on-year. 9. Genscript Biotech (01548.HK) issued a profit warning: 2025 net loss is expected to be approximately US$506 million to US$586 million, a reversal from profit to loss year-on-year. 10. Ascletis Pharma-B (01672.HK): Positive top-line results were obtained from a 24-week Phase II trial in the US for the long-acting subcutaneous depot formulation of the small molecule GLP-1R agonist ASC30 for the indication of obesity. 11. NIO (09866.HK): Gross profit for the fourth quarter of 2025 is expected to be RMB 6.0741 billion, a year-on-year increase of 163.1% and a quarter-on-quarter increase of 100.8%; first-quarter revenue is expected to be RMB 24.482 billion to RMB 25.176 billion.